Breaking News

Ratio Therapeutics to Build a Radiopharmaceutical Manufacturing Facility in Utah

The 65,000 square foot manufacturing facility will support vertical integration of Ratio’s current and future pipeline of next-generation radiopharmaceuticals.

Author Image

By: Charlie Sternberg

Associate Editor

Ratio Therapeutics Inc., a pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment and monitoring, has entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group to partner and construct a radiopharmaceutical research and manufacturing facility in Salt Lake City, Utah, anticipated to be fully operational in the second half of 2027. This 65,000 square foot manufacturing facility will support vertical integration of Ra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters